APA

Huet S., Cony-Makhoul P., Heiblig M., Tigaud I., Gazzo S., Belhabri A., Souche D., Michallet M., Magaud J., Hayette S. & Nicolini F. (20150518). Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended. : PloS one.

Chicago

Huet Sarah, Cony-Makhoul Pascale, Heiblig Maël, Tigaud Isabelle, Gazzo Sophie, Belhabri Amine, Souche Denis, Michallet Mauricette, Magaud Jean-Pierre, Hayette Sandrine and Nicolini Franck. 20150518. Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended. : PloS one.

Harvard

Huet S., Cony-Makhoul P., Heiblig M., Tigaud I., Gazzo S., Belhabri A., Souche D., Michallet M., Magaud J., Hayette S. and Nicolini F. (20150518). Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended. : PloS one.

MLA

Huet Sarah, Cony-Makhoul Pascale, Heiblig Maël, Tigaud Isabelle, Gazzo Sophie, Belhabri Amine, Souche Denis, Michallet Mauricette, Magaud Jean-Pierre, Hayette Sandrine and Nicolini Franck. Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended. : PloS one. 20150518.